Category

UF Startup

Putting Drones and Smart AI to Work

Dr. Yiannis Ampatzidis and Matt Donovan are the developers of Agroview, a Florida startup invention and a 2020 Cade Prize finalist. A spinoff company located at UF Innovate | The Hub called “Agriculture Intelligence Inc.,” was created, which provides Agroview’s services to growers.

SharpSpring Announces Winning Three New TrustRadius Awards

UF startup SharpSpring, Inc., a leading cloud-based sales and marketing automation platform, announced that it has been named first place for Best Usability, Best Feature Set Award and Best Customer Support on TrustRadius, a B2B software technology review platform.

VetGuardian Is Working on Wireless Veterinary Care

Vik Ramprakash, CEO of UF startup Structured Monitoring Products Inc, has developed a solution called VetGuardian, a wireless device that sits a few feet away from the animal and requires no connection points to monitor the animal's vitals.

COVID-19 Fighting Antibodies Developed in Alachua Sent to Clinical Trials

Supporting our troops: an Alachua company works to keep our soldiers safe from COVID-19. Here's what UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), is doing on the front lines of the pandemic.

Ology Bioservices Signs Built-to-Suit Lab Space, Adding 43,000 Square Feet to Headquarters

Avison Young facilitated a 42,500-square-foot lease agreement between Concept Companies and Ology Bioservices, a UF startup and UF Innovate | Sid Martin Biotech alum, for a new built-to-suit lab space on the heels of a federal government contract for the company to expand production capabilities, including vaccines and therapeutics for COVID-19 once finalized.

Atsena Therapeutics Raises $55 Million Series A Financing to Advance LCA1 Gene Therapy Clinical Program, Two Preclinical Assets, and Novel Capsid Development for Ocular Diseases

UF startup Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, announced it has closed an oversubscribed $55 million Series A financing led by Sofinnova Investments with participation from additional new investors Abingworth and Lightstone Ventures.